Search Results
Results for: VARIAN (Save this search)
Number of Results: 104
Healthgrades Acquires Evariant to Strengthen Consumer/Physician Engagement Platform
13 January 2020 - US Healthgrades, a resource that connects consumers, physicians and health systems, has acquired US healthcare engagement company Evariant to strengthen healthcar...

HEALTHGRADES ACQUIRES EVARIANT
US Healthgrades, a resource that connects consumers, physicians and health systems, has acquired US healthcare engagement company Evariant to strengthen healthcare industry ene-to-...

VARIAN COMPLETES PURCHASE OF EMBOLIC BEAD ASSET FROM BOSTON SCIENTIFIC
US-based medical technology company Varian (NYSE: VAR) has completed its asset purchase of the US-based medical technology company Boston Scientific Corp. (NYSE: BSX) portfoli...

Varian Completes Purchase of Embolic Bead Asset from Boston Scientific
27 August 2019 - US-based medical technology company Varian (NYSE: VAR) has completed its asset purchase of the US-based medical technology company Boston Scientific Corp. (NY...

Varian to Expand Interventional Oncology Portfolio with Acquisition of Embolic Bead Asset
11 July 2019 - US-based drug developer Varian (NYSE: VAR) has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland e...

VARIAN TO EXPAND PORTFOLIO WITH ACQUISITION OF EMBOLIC BEAD ASSET
US-based drug developer Varian (NYSE: VAR) has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead pro...

Varian to Expand Interventional Oncology Portfolio with Acquisition of Embolic Bead Asset
11 July 2019 - US-based drug developer Varian (NYSE: VAR) has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland e...

Varian Closes USD 283m Acquisition of Cancer Treatment Services International
18 June 2019 - California, US-based Varian Medical Systems (NYSE: VAR) has closed the acquisition of India-based Cancer Treatment Services International (CTSI) for USD 283m, t...

Savanna Capital Proposes Acquisition of Colombia-Based Varianz
12 June 2019 - Canada-based capital pool company Savanna Capital Corp. (TSX Venture: SAC.P) has entered into a binding letter of intent with Colombia-based biotech company Varianz ...

You can compare news articles by clicking on the tick buttons
1   2   3   4   5   6   7   8   9   10   11   >